[1] Sacco RL, Roth GA, Reddy KS, et al. The Heart of 25 by 25: achieving the goal of reducing global and regional premature deaths from cardiovascular diseases and stroke: a modeling study from the American heart association and world heart federation. Circulation, 2016; 133, e674−90.
[2] The Writing Committee of the Report on Cardiovascular Health Diseases in China. Profile of the Chinese cardiovascular health diseases report 2019. Cardio-Cerebrovasc Dis Prev Treat, 2020; 20, 437−50. (In Chinese
[3] Wang Y, Cao XX, Hou YB, et al. C Study on Chinese and global cardiovascular diseases burden in 1990 and 2017. Chin JPrev Control Chronic Dis, 2020; 28, 10−3, 19. (In Chinese
[4] Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts)developed with the special contribution of the European association for cardiovascular prevention & rehabilitation (EACPR). Eur Heart J, 2016; 37, 2315−81. doi:  10.1093/eurheartj/ehw106
[5] Goff DJ Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol, 2014; 63, 2935−59. doi:  10.1016/j.jacc.2013.11.005
[6] Cheung BM, Cheng CH, Lau CP, et al. 2016 Consensus statement on prevention of atherosclerotic cardiovascular disease in the Hong Kong population. Hong Kong Med J, 2017; 23, 191−201.
[7] Chinese Journal of Cardiology Editorial Board, China Cardiovascular Disease Prevention Guidelines Writing Group. China cardiovascular disease prevention guidelines (2017). Chin J Cardiol, 2018; 46, 10−25. (In Chinese
[8] Tsao CW, Vasan RS. Cohort profile: the Framingham heart study (FHS): overview of milestones in cardiovascular epidemiology. Int J Epidemiol, 2015; 44, 1800−13. doi:  10.1093/ije/dyv337
[9] D'Agostino RB, Grundy S, Sullivan LM, et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA, 2001; 286, 180−7. doi:  10.1001/jama.286.2.180
[10] Hua XY, McDermott R, Lung T, et al. Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort. Eur J Prev Cardiol, 2017; 24, 1660−9. doi:  10.1177/2047487317722913
[11] Chow CK, Joshi R, Celermajer DS, et al. Recalibration of a Framingham risk equation for a rural population in India. J Epidemiol Community Health, 2009; 63, 379−85. doi:  10.1136/jech.2008.077057
[12] Leung JY, Lin SL, Lee RS, et al. Framingham risk score for predicting cardiovascular disease in older adults in Hong Kong. Hong Kong Med J, 2018; 24 Suppl 4, 8−11.
[13] Goh LGH, Welborn TA, Dhaliwal SS. Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: a mortality follow-up study. BMC Women’s Health, 2014; 14, 118. doi:  10.1186/1472-6874-14-118
[14] Chia YC, Gray SYW, Ching SM, et al. Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study. BMJ Open, 2015; 5, e007324. doi:  10.1136/bmjopen-2014-007324
[15] Ahmad A, Didia SC. Effects of sleep duration on cardiovascular events. Curr Cardiol Rep, 2020; 22, 18. doi:  10.1007/s11886-020-1271-0
[16] Knutson KL. Sleep duration and cardiometabolic risk: a review of the epidemiologic evidence. Best Pract Res Clin Endocrinol Metab, 2010; 24, 731−43. doi:  10.1016/j.beem.2010.07.001
[17] Cappuccio FP, Cooper D, D'Elia L, et al. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J, 2011; 32, 1484−92. doi:  10.1093/eurheartj/ehr007
[18] Strand LB, Tsai MK, Gunnell D, et al. Self-reported sleep duration and coronary heart disease mortality: a large cohort study of 400, 000 Taiwanese adults. Int J Cardiol, 2016; 207, 246−51. doi:  10.1016/j.ijcard.2016.01.044
[19] Lao XQ, Liu XD, Deng HB, et al. Sleep quality, sleep duration, and the risk of coronary heart disease: a prospective cohort study with 60, 586 adults. J Clin Sleep Med, 2018; 14, 109−17. doi:  10.5664/jcsm.6894
[20] Pergola BL, Moonie S, Pharr J, et al. Sleep duration associated with cardiovascular conditions among adult Nevadans. Sleep Med, 2017; 34, 209−16. doi:  10.1016/j.sleep.2017.03.006
[21] Ford ES. Habitual sleep duration and predicted 10-year cardiovascular risk using the pooled cohort risk equations among US adults. J Am Heart Assoc, 2014; 3, e001454.
[22] Yazdanpanah MH, Homayounfar R, Khademi A, et al. Short sleep is associated with higher prevalence and increased predicted risk of cardiovascular diseases in an Iranian population: Fasa PERSIAN cohort study. Sci Rep, 2020; 10, 4608. doi:  10.1038/s41598-020-61506-0
[23] Cole HV, Owusu-Dabo E, Iwelunmor J, et al. Sleep duration is associated with increased risk for cardiovascular outcomes: a pilot study in a sample of community dwelling adults in Ghana. Sleep Med, 2017; 34, 118−25. doi:  10.1016/j.sleep.2017.03.008
[24] Im E, Kim GS. Relationship between sleep duration and Framingham cardiovascular risk score and prevalence of cardiovascular disease in Koreans. Medicine, 2017; 96, e7744. doi:  10.1097/MD.0000000000007744
[25] Li F, Sun K, Lin DZ, et al. Longtime napping is associated with cardiovascular risk estimation according to Framingham risk score in postmenopausal women. Menopause, 2016; 23, 950−6. doi:  10.1097/GME.0000000000000661
[26] Krittanawong C, Tunhasiriwet A, Wang Z, et al. Association between short and long sleep durations and cardiovascular outcomes: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care, 2019; 8, 762−70. doi:  10.1177/2048872617741733
[27] D'Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation, 2008; 117, 743−53. doi:  10.1161/CIRCULATIONAHA.107.699579
[28] Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation, 2010; 121, 1768−77. doi:  10.1161/CIRCULATIONAHA.109.849166
[29] Liu LS, Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. 2010 Chinese guidelines for the management of hypertension. Chin J Cardiol, 2011; 39, 579−616. (In Chinese
[30] Chen CM, Lu FC, Department of Disease Control Ministry of Health, PR China. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci, 2004; 17, 1−36.
[31] Anujuo K, Agyemang C, Snijder MB, et al. Contribution of short sleep duration to ethnic differences in cardiovascular disease: results from a cohort study in the Netherlands. BMJ Open, 2017; 7, e017645. doi:  10.1136/bmjopen-2017-017645
[32] Rao MN, Neylan TC, Grunfeld C, et al. Subchronic sleep restriction causes tissue-specific insulin resistance. J Clin Endocrinol Metab, 2015; 100, 1664−71. doi:  10.1210/jc.2014-3911
[33] Xiao Q, Arem H, Moore SC, et al. A large prospective investigation of sleep duration, weight change, and obesity in the NIH-AARP diet and health study cohort. Am J Epidemiol, 2013; 178, 1600−10. doi:  10.1093/aje/kwt180
[34] Grandner MA, Sands-Lincoln MR, Pak VM, et al. Sleep duration, cardiovascular disease, and proinflammatory biomarkers. Nat Sci Sleep, 2013; 5, 93−107.
[35] Besedovsky L, Lange T, Born J. Sleep and immune function. Pflugers Arch, 2012; 463, 121−37. doi:  10.1007/s00424-011-1044-0
[36] Mallon L, Broman JE, Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care, 2005; 28, 2762−7. doi:  10.2337/diacare.28.11.2762
[37] Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension: analyses of the first national health and nutrition examination survey. Hypertension, 2006; 47, 833−9. doi:  10.1161/01.HYP.0000217362.34748.e0
[38] Hasler G, Buysse DJ, Klaghofer R, et al. The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep, 2004; 27, 661−6. doi:  10.1093/sleep/27.4.661
[39] Gangwisch JE, Malaspina D, Boden-Albala B, et al. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep, 2005; 28, 1289−96. doi:  10.1093/sleep/28.10.1289
[40] Patterson F, Malone SK, Lozano A, et al. Smoking, screen-based sedentary behavior, and diet associated with habitual sleep duration and chronotype: data from the UK biobank. Ann Behav Med, 2016; 50, 715−26. doi:  10.1007/s12160-016-9797-5
[41] Nakata A, Takahashi M, Haratani T, et al. Association of active and passive smoking with sleep disturbances and short sleep duration among Japanese working population. Int J Behav Med, 2008; 15, 81. doi:  10.1080/10705500801929577
[42] Van Schrojenstein LM, Mackus M, Roth T, et al. Total sleep time, alcohol consumption, and the duration and severity of alcohol hangover. Nat Sci Sleep, 2017; 9, 181−6. doi:  10.2147/NSS.S136467
[43] Chaput JP, McNeil J, Després JP, et al. Short sleep duration is associated with greater alcohol consumption in adults. Appetite, 2012; 59, 650−5. doi:  10.1016/j.appet.2012.07.012
[44] Morioka H, Itani O, Kaneita Y, et al. Associations between sleep disturbance and alcohol drinking: a large-scale epidemiological study of adolescents in Japan. Alcohol, 2013; 47, 619−28. doi:  10.1016/j.alcohol.2013.09.041
[45] Lakerveld J, Mackenbach JD, Horvath E, et al. The relation between sleep duration and sedentary behaviours in European adults. Obes Rev, 2016; 17, 62−7. doi:  10.1111/obr.12381
[46] Štefan L, Horvatin M, Baić M. Are sedentary behaviors associated with sleep duration? A cross-sectional case from Croatia. Int J Environ Res Public Health, 2019; 16, 200. doi:  10.3390/ijerph16020200
[47] Qureshi AI, Giles WH, Croft JB, et al. Habitual sleep patterns and risk for stroke and coronary heart disease: A 10-year follow-up from NHANES I. Neurology, 1997; 48, 904−11. doi:  10.1212/WNL.48.4.904
[48] Ikehara S, Iso H, Date C, et al. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep, 2009; 32, 295−301. doi:  10.1093/sleep/32.3.295
[49] Kim Y, Wilkens LR, Schembre SM, et al. Insufficient and excessive amounts of sleep increase the risk of premature death from cardiovascular and other diseases: the multiethnic cohort study. Prev Med, 2013; 5, 377−85.
[50] Magee CA, Holliday EG, Attia J, et al. Investigation of the relationship between sleep duration, all-cause mortality, and preexisting disease. Sleep Med, 2013; 14, 591−6. doi:  10.1016/j.sleep.2013.02.002
[51] Williams CJ, Hu FB, Patel SR, et al. Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes. Diabetes Care, 2007; 30, 1233−40. doi:  10.2337/dc06-2107
[52] Patel SR, Malhotra A, Gao X, et al. A prospective study of sleep duration and pneumonia risk in women. Sleep, 2012; 35, 97−101. doi:  10.5665/sleep.1594
[53] Ge BH, Guo XM. Short and long sleep durations are both associated with increased risk of stroke: a meta-analysis of observational studies. Int J Stroke, 2015; 10, 177−84. doi:  10.1111/ijs.12398
[54] Meisinger C, Heier M, Löwel H, et al. Sleep duration and sleep complaints and risk of myocardial infarction in middle-aged men and women from the general population: the MONICA/KORA Augsburg cohort study. Sleep, 2007; 30, 1121−7. doi:  10.1093/sleep/30.9.1121
[55] Hoevenaar-Blom MP, Spijkerman AMW, Kromhout D, et al. Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: the MORGEN study. Sleep, 2011; 34, 1487−92. doi:  10.5665/sleep.1382
[56] Basner M, Fomberstein KM, Razavi FM, et al. American time use survey: sleep time and its relationship to waking activities. Sleep, 2007; 30, 1085−95. doi:  10.1093/sleep/30.9.1085
[57] Kronholm E, Härmä M, Hublin C, et al. Self-reported sleep duration in Finnish general population. J Sleep Res, 2006; 15, 276−90. doi:  10.1111/j.1365-2869.2006.00543.x
[58] Jean-Louis G, Kripke DF, Ancoli-Israel S. Sleep and quality of well-being. Sleep, 2000; 23, 1115−21.
[59] Kronholm E, Partonen T, Laatikainen T, et al. Trends in self-reported sleep duration and insomnia-related symptoms in Finland from 1972 to 2005: a comparative review and re-analysis of Finnish population samples. J Sleep Res, 2008; 17, 54−62. doi:  10.1111/j.1365-2869.2008.00627.x
[60] Hale L, Parente V, Dowd JB, et al. Fibrinogen may mediate the association between long sleep duration and coronary heart disease. J Sleep Res, 2013; 22, 305−14. doi:  10.1111/jsr.12020